$HENGRUI PHARMA(01276.HK) saw a slight rise, and $Intuitive Surgical(ISRG.US) is also rising, though the magnitude is not large. The common point between innovative drugs and surgical robots right now is—valuations are already not cheap, but fundamentals haven't given reasons to be disappointed yet😀
$HENGRUI PHARMA(01276.HK)'s external licensing pace has been solid these past two years, and $Intuitive Surgical(ISRG.US)'s installation volume and consumable revenue have remained steady. Such targets usually aren't the first to rise when liquidity eases, but it's also hard for them to fall.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
